Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reidar Fossmark

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Gastroenterology & Hepatology|November 18, 2005
Idiopathic gastric acid hypersecretionHelge L Waldum, Reidar Fossmark
Gastroenterology|October 10, 2022
Proton Pump Inhibitors and MortalityHelge L Waldum, Reidar Fossmark
JAMA Internal Medicine|June 9, 2016
Adverse Effects of Proton Pump Inhibitors in Chronic Kidney DiseaseEivind Ness-Jensen, Reidar Fossmark
Gut|November 22, 2017
Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in manHelge Lyder Waldum, Reidar Fossmark
Scandinavian Journal of Gastroenterology|March 14, 2007
pH 4.0Reidar Fossmark, Eiliv Brenna, Helge L Waldum
Scandinavian Journal of Gastroenterology|June 2, 2018
Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequencesHelge L Waldum, Øystein Sørdal, Reidar Fossmark
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 14, 2013
[Who should perform endoscopies?]Reidar Fossmark, Michael Bretthauer, Bjørn I Gustafsson
World Journal of Gastroenterology|March 20, 2008
Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemiaReidar Fossmark, Gunnar Qvigstad, Helge-L Waldum
BMC Gastroenterology|September 6, 2023
Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?Reidar Fossmark, Eivind Ness-Jensen, Øystein Sørdal
Medicina (Kaunas, Lithuania)|April 23, 2022
Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin?Reidar Fossmark, Rune Johannessen, Gunnar Qvigstad, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Gastroenterology & Hepatology|November 18, 2005
Idiopathic gastric acid hypersecretionHelge L Waldum, Reidar Fossmark
Gastroenterology|October 10, 2022
Proton Pump Inhibitors and MortalityHelge L Waldum, Reidar Fossmark
JAMA Internal Medicine|June 9, 2016
Adverse Effects of Proton Pump Inhibitors in Chronic Kidney DiseaseEivind Ness-Jensen, Reidar Fossmark
Gut|November 22, 2017
Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in manHelge Lyder Waldum, Reidar Fossmark
Scandinavian Journal of Gastroenterology|March 14, 2007
pH 4.0Reidar Fossmark, Eiliv Brenna, Helge L Waldum
Scandinavian Journal of Gastroenterology|June 2, 2018
Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequencesHelge L Waldum, Øystein Sørdal, Reidar Fossmark
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 14, 2013
[Who should perform endoscopies?]Reidar Fossmark, Michael Bretthauer, Bjørn I Gustafsson
World Journal of Gastroenterology|March 20, 2008
Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemiaReidar Fossmark, Gunnar Qvigstad, Helge-L Waldum
BMC Gastroenterology|September 6, 2023
Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?Reidar Fossmark, Eivind Ness-Jensen, Øystein Sørdal
Medicina (Kaunas, Lithuania)|April 23, 2022
Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin?Reidar Fossmark, Rune Johannessen, Gunnar Qvigstad, et al.
Pageof 11